26 Nov 2022 , 01:34 AM
Alembic Pharmaceuticals has received final approval from the US Food Drug Administration USFDA for its Abbreviated New Drug Application ANDA Nifedipine Extended-Release Tablets USP 30 mg 60 mg and 90 mg The approved ANDA is therapeutically equivalent to the reference listed drug product RLD Procardia XL Extended-Release Tablets 30 mg 60 mg and 90mg of Pfizer Inc Nifedipine Extended-Release Tablets are indicated for the management of i Vasospastic Angina ii Chronic Stable Angina Classical Effort Associated Angina and iii Hypertension Nifedipine Extended-Release Tablets USP 30 mg 60 mg and 90 mg have an estimated market size of US$ 56 million for twelve months ending Sep 2022 according to IQVIA
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.